223 related articles for article (PubMed ID: 10665776)
1. Minor role of the C3a receptor in systemic anaphylaxis in the guinea pig.
Regal JF; Klos A
Immunopharmacology; 2000 Jan; 46(1):15-28. PubMed ID: 10665776
[TBL] [Abstract][Full Text] [Related]
2. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
Regal JF; Fraser DG; Toth CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human C5a-induced bronchoconstriction in the guinea pig: inhibition by an H1 antagonist after depletion of circulating granulocytes and platelets.
Fraser DG; Regal JF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1213-20. PubMed ID: 1684819
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma.
Bautsch W; Hoymann HG; Zhang Q; Meier-Wiedenbach I; Raschke U; Ames RS; Sohns B; Flemme N; Meyer zu Vilsendorf A; Grove M; Klos A; Köhl J
J Immunol; 2000 Nov; 165(10):5401-5. PubMed ID: 11067890
[TBL] [Abstract][Full Text] [Related]
5. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human C5a-induced bronchoconstriction in the guinea-pig: a histamine independent mechanism.
Regal JF; Fraser DG
Pulm Pharmacol; 1990; 3(2):79-87. PubMed ID: 2135212
[TBL] [Abstract][Full Text] [Related]
7. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
[TBL] [Abstract][Full Text] [Related]
8. Anaphylactic actions of platelet-activating factor.
Stimler NP; Bloor CM; Hugli TE; Wykle RL; McCall CE; O'Flaherty JT
Am J Pathol; 1981 Oct; 105(1):64-9. PubMed ID: 6975043
[TBL] [Abstract][Full Text] [Related]
9. Effect of the hetrazepinoic platelet-activating factor antagonist Bepafant (WEB 2170) in models of active and passive anaphylaxis in mice and guinea pigs.
Heuer HO
Lipids; 1991 Dec; 26(12):1374-80. PubMed ID: 1819736
[TBL] [Abstract][Full Text] [Related]
10. Activation of the third complement component (C3) and C3a generation in cardiac anaphylaxis: histamine release and associated inotropic and chronotropic effects.
del Balzo U; Polley MJ; Levi R
J Pharmacol Exp Ther; 1988 Sep; 246(3):911-6. PubMed ID: 2458450
[TBL] [Abstract][Full Text] [Related]
11. Cardiac anaphylaxis. Complement activation as an amplification system.
del Balzo U; Polley MJ; Levi R
Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological modulation of bronchial anaphylaxis induced by aerosol challenge in anaesthetized guinea-pigs.
Daffonchio L; Lees IW; Payne AN; Whittle BJ
Br J Pharmacol; 1987 Jul; 91(3):701-8. PubMed ID: 3607373
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning of two isoforms of the guinea pig C3a anaphylatoxin receptor: alternative splicing in the large extracellular loop.
Fukuoka Y; Ember JA; Hugli TE
J Immunol; 1998 Sep; 161(6):2977-84. PubMed ID: 9743361
[TBL] [Abstract][Full Text] [Related]
14. Complement factors C3a and C5a have distinct hemodynamic effects in the rat.
Proctor LM; Moore TA; Monk PN; Sanderson SD; Taylor SM; Woodruff TM
Int Immunopharmacol; 2009 Jun; 9(6):800-6. PubMed ID: 19285573
[TBL] [Abstract][Full Text] [Related]
15. Anti-anaphylactic action of nordihydroguaiaretic acid in antigen sensitized guinea pigs.
Bergren DR; Valentine JL
Respir Physiol Neurobiol; 2016 Dec; 234():26-31. PubMed ID: 27595978
[TBL] [Abstract][Full Text] [Related]
16. Role of kinins in anaphylactic-induced bronchoconstriction mediated by tachykinins in guinea-pigs.
Ricciardolo FL; Nadel JA; Graf PD; Bertrand C; Yoshihara S; Geppetti P
Br J Pharmacol; 1994 Oct; 113(2):508-12. PubMed ID: 7834202
[TBL] [Abstract][Full Text] [Related]
17. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
Marceau F; Hugli TE
J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
[TBL] [Abstract][Full Text] [Related]
18. Effect of ibudilast, a novel antiasthmatic agent, on anaphylactic bronchoconstriction: predominant involvement of endogenous slow reacting substance of anaphylaxis.
Ohashi M; Uno T; Nishino K
Int Arch Allergy Immunol; 1993; 101(3):288-96. PubMed ID: 8324390
[TBL] [Abstract][Full Text] [Related]
19. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.
Desquand S; Lefort J; Dumarey C; Vargaftig BB
Br J Pharmacol; 1991 Mar; 102(3):687-95. PubMed ID: 1285397
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of NZ-107 on anaphylactic bronchoconstriction in guinea pigs and rats.
Iwama T; Shikada K; Yamamoto A; Sakashita M; Hibi M; Tanaka S
Int Arch Allergy Immunol; 1992; 97(2):99-104. PubMed ID: 1582710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
